Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Folinic Acid Rescue Following Methotrexate (MTX) Graft-versus-host Disease (GVHD) Prophylaxis on Regimen Related Toxicity and Transplantation Outcome: a Double Blind Randomized Controlled Study

NCT02506231 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02506231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02506231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Folinic Acid Rescue Following Methotrexate (MTX) Graft-versus-host Disease (GVHD) Prophylaxis on Regimen Related Toxicity and Transplantation Outcome: a Double Blind Randomized Controlled Study
Lead sponsor
Rabin Medical Center
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2015
Completion date
Not reported
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic hematopoietic cell transplantation, graft vs host disease, mucositis